Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard Therapies

NCT00081549 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Neoplasms

Interventions

DRUG: Aroplatin (Liposomal NDDP, L-NDDP)

Sponsor

Aronex Pharmaceuticals